UPDATE 3-Boston Scientific regains market share, stock up
105301
Boston Scientific Corp. (BSX.N: Quote, Profile, Research) said on Wednesday it already recovered market share for its popular heart device after a recent recall
610048
Stock indexes gained on Monday as deal news and pharmaceutical sector profits renewed optimism about the equities market after Friday's sell-off.
322082
Stocks rose on Monday, lifted by takeover news and data showing stronger manufacturing growth in June even as price pressures eased.
266759
Stocks rebounded on Monday from last week's losses after IBM  reported higher-than-expected preliminary quarterly earnings, spurring a broader rally in technology shares.
183643
US stocks rose, led by technology shares after Dell Inc.&#39;s chief executive officer said demand at the world&#39;s No. 1 personal-computer maker is ``healthy.
362793
Standard &amp; Poor&#39;s Equity Research lowered the price target for Boston Scientific (nyse: BSX - news - people ) to $41 from $44 and said the company&#39;s dispute with former partner Medinol will likely go to trial next year.
634908
International Business Machines Corp. stock rose in pre-market trading Tuesday, a day after the the company reported better than expected earnings for the third quarter.
367969
Shares in Boston Scientific Corp. slumped yesterday after the company said its top-selling product can cause blood clots in patients' coronary arteries.
424418
U.S. stocks recovered from earlier  losses and rose early Thursday afternoon, with National  Semiconductor Corp. NSM.N shares surging after the chip maker  said problems with excess inventory in the distribution channel  are behind it.
90426
Stocks rose on Monday, led by financial companies, after Merrill Lynch  took steps to shore up its balance sheet with plans to raise up to $6.2 billion and sell a lending unit.
83024
U.S. stocks rebounded on Wednesday, with the S&P and Nasdaq rising more than 2 percent, led by technology companies as investors snapped up beaten down shares, while the energy sector benefited from a surge in oil prices.
704148
Shares of NeoPharm Inc. jumped 7 percent Thursday morning after the troubled biotechnology company said it regained licenses for two key cancer medications from Pfizer Inc.
261985
BOSTON (CBS.MW) -- Shares of NeoPharm rallied nearly 4 percent Thursday after the drug-delivery developer said it has regained commercialization rights to two drugs previously licensed to pharmaceutical giant Pfizer.
308614
Boston Scientific provided fresh evidence in its strong quarterly earnings report Tuesday that it reigns supreme in the market for drug-coated stents.
413664
Stocks rose on Monday, boosted by takeover news and data that showed manufacturing growth quickened in June even as price pressures eased.
445058
Bloomington (Star report) --Boston Scientific Corp. has obtained exclusive rights to sell the most popular coating on heart stents, taking over the share previously held by Cook Inc.
317754
The Dow industrials and the S&P 500 rose on Monday, led by health-care and consumer staple shares, as investors snapped up stock in companies seen able to withstand any economic slowdown following dismal employment data last Friday.